FDA Approved: CILOSTAZOL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for cilostazol submitted by Teva Pharmaceuticals USA, Inc., resulting in changes to the drug's labeling under the su…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intermittent Claudication
• Peripheral Artery Disease

Drugs mentioned

• Cilostazol (Cilostazol)

Snippet

SUPPL AP for CILOSTAZOL (CILOSTAZOL)